New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2014
09:01 EDTDSCIDerma Sciences 6.522M share Spot Secondary priced at $11.50
Piper Jaffray and Canaccord acted as joint book running managers for the offering.
News For DSCI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 20, 2015
15:30 EDTDSCIBroadfin Capital raises stake in Derma Sciences to 8.3% from 7.4%
On March 19, Broadfin Capital and certain of its affiliates entered into a letter agreement with Derma Sciences. Pursuant to the Settlement Agreement, the company agreed to nominate Samuel E. Navarro for election to its Board of Directors at the 2015 annual meeting of the stockholders, and not to nominate C. Richard Stafford, a current member of the Board, for election. Furthermore, the company granted Broadfin the right to designate a replacement candidate for Navarro in the event Navarro is unable, or at any time ceases, to serve as a director of the company, for so long as Broadfin owns at least 5% of the outstanding Shares of the company. Derma Sciences also agreed to entered into a Consulting Agreement with Jason M. Aryeh for various strategic consulting services in order to increase stockholder value. Broadfin agreed, amongst other things, not to engage in proxy solicitation activities with respect to the 2015 Annual Meeting and to cause all of its Shares to be voted in favor of the director candidates nominated by the Board for election at the 2015 Annual Meeting.
March 18, 2015
11:34 EDTDSCIBroadfin Capital reports 8.3% stake in Derma Sciences, will continue talks
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use